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Summary
Multiple epiphyseal dysplasia (MED), an autosomal
dominant osteochondrodysplasia, is a clinically and ge-
netically heterogeneous disorder characterized by mild
short stature and early-onset osteoarthritis. The phe-
notypic spectrum includes the mild Ribbing type, the
more severe Fairbank type, and some unclassified forms.
Linkage studies have identified two loci for MED. One
of these, EDM1, is on chromosome 19, in a region that
contains the cartilage oligomeric matrix protein
(COMP) gene. Mutations have been identified in this
gene in patients with the Ribbing type, the Fairbank
type, and unclassified forms of MED. The second locus,
EDM2, maps to chromosome 1, in a region spanning
COL9A2. Recently, a splice-site mutation was found in
COL9A2, causing skipping of exon 3 in one family with
MED. Because of the exclusion of the EDM1 and EDM2
loci in some families, the existence of a third locus has
been postulated. We report here one family with MED,
evaluated clinically and radiologically and tested for
linkage with candidate genes, including COMP,
COL9A1, COL9A2, and COL9A3. No linkage was
found with COMP, COL9A1, or COL9A2, but an in-
heritance pattern consistent with linkage was observed
with COL9A3.Mutation analysis of COL9A3 identified
an ArT transversion in the acceptor splice site of intron
2 in affected family members. The mutation led to skip-
ping of exon 3 and an in-frame deletion of 12 amino
acid residues in the COL3 domain of the a3(IX) chain
and thus appeared to be similar to that reported for
COL9A2. This is the first disease-causingmutation iden-
tified in COL9A3. Our results also show that COL9A3,
located on chromosome 20, is a third locus for MED.
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Introduction
Multiple epiphyseal dysplasia (MED; MIM 132400) is
an autosomal dominantly inherited osteochondrodys-
plasia characterized by mild-to-moderate short stature
and early-onset osteoarthritis. MED consists of the clin-
ically overlapping Ribbing and Fairbank phenotypes as
well as other forms (International Working Group on
Constitutional Diseases of Bone 1998). The symptoms
include pain and stiffness of multiple joints during child-
hood and adolescence and development of osteoarthritis
in late childhood to adulthood. Affected individuals usu-
ally have a slightly shorter stature than their unaffected
siblings, and they may have short, stubby fingers. Ra-
diographic features show irregular and flattened epiph-
yses with delayed ossification. The vertebrae and me-
taphyses are usually unaffected (Weaver et al. 1993;
Rimoin et al. 1994). Some patients have been reported
to have only radiological evidence of MED or osteoar-
thritis in the absence of complaints (Oehlmann et al.
1994; van Mourik et al. 1998).
In addition to its clinical heterogeneity, MED is also
a genetically heterogeneous disease. It can be caused by
mutations in the cartilage oligomeric matrix protein
(COMP; MIM 600310) gene (EDM1; MIM 132400),
or in the COL9A2 gene that encodes the a2 chain of
collagen IX (EDM2; MIM 600204). COMP is located
on chromosome 19 (Newton et al. 1994) and COL9A2
is located on chromosome 1 (Pera¨la¨ et al. 1993). Mu-
tations resulting in Ribbing, Fairbank, and unclassified
forms of MED have been identified in COMP (Briggs
et al. 1995; Cohn et al. 1996; Ballo et al. 1997; Susic
et al. 1997; Briggs et al. 1998; Loughlin et al. 1998).
Furthermore, EDM1 and pseudoachondroplasia
(PSACH) have proved to be allelic disorders because
mutations in COMP have also been identified in patients
with PSACH (Briggs et al. 1995, 1998; Hecht et al. 1995;
Maddox et al. 1997; Susic et al. 1997; Loughlin et al.
1998). PSACH is more severe than MED, but the phe-
notypes of its mild forms overlap with those of MED
(Maroteaux et al. 1980; Wynne-Davies et al. 1986; Ri-
moin et al. 1994; Briggs et al. 1998).
Collagen IX is a heterotrimeric nonfibrillar collagen
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Figure 1 Pedigree of family with MED. Blackened symbols indicate affected individuals. The proband is marked by an arrow. Subject
II-4 (shown by circle within open square) did not have any complaints, and the results of a physical examination were normal. The affected
status could not be determined by roentgenogram analysis, because radiologic examination was refused. Alleles of the indicated markers are
shown below the symbols.
consisting of three different a chains, a1(IX), a2(IX),
and a3(IX), that are encoded by three distinct genes,
COL9A1, COL9A2, and COL9A3 (van der Rest and
Mayne 1987; Shaw and Olsen 1991). Each polypeptide
chain consists of three collagenous domains, COL1–
COL3, interrupted by four noncollagenous domains,
NC1–NC4. The domains are numbered from the C ter-
minus. Collagen IX is a structural component of hyaline
cartilage, intervertebral discs, and the vitreous body of
the eye. Its precise function is not well established, al-
though a possible role in the stabilization of the fibril
network has been suggested (Bruckner et al. 1988). Re-
sults obtained with transgenic mice suggest that collagen
IX is needed for the long-term structural integrity of
cartilage (Nakata et al. 1993; Fa¨ssler et al. 1994; Haimes
et al. 1995). Muragaki et al. (1996) and van Mourik et
al. (1998) reported that a splice-site mutation in
COL9A2 has been shown to cause MED of an unclas-
sified form in one family. This mutation caused skipping
of exon 3 and thus in-frame deletion of 12 amino acid
residues in the COL3 domain of the a2(IX) chain.
Linkage with the EDM1 and EDM2 loci has been
excluded in one family with MED, which suggests the
existence of at least one additional locus (EDM3; MIM
600969; Deere et al. 1995). We searched for additional
loci by analyzing a family with an unclassified form of
MED for linkage with candidate genes, including
COMP, COL9A1, COL9A2, and COL9A3. Whereas
linkage with COL9A1, COL9A2, and COMP was ex-
cluded, no recombination was observed between the
phenotype and COL9A3. Mutation analysis of
COL9A3 identified a splice-site mutation leading to an
in-frame deletion of 12 amino acid residues in the COL3
domain of the a3(IX) chain. This is the first disease-
causing mutation to be identified in COL9A3. The re-
sults also show COL9A3 to be a third locus for MED.
Subjects and Methods
Subjects
Members of a four-generation family with MED were
studied. Clinical and radiologic examinations were per-
formed on six affected family members and four unaf-
fected ones. After informed consent, blood samples were
taken from the family members, for DNA analysis.
Blood samples were also obtained from 65 healthy vol-
unteers, for DNA analysis.
Linkage Analysis
Intragenic markers were used to perform linkage anal-
ysis onCOL9A1 andCOL9A3.A tetranucleotide repeat
in intron 12 of COL9A1 had been reported elsewhere
(Pihlajamaa et al. 1998). Exon 5 of COL9A3, which
contains a neutral GrA sequence variation (CGGr
CAG), was amplified with the PCR primers FI5, 5′-CA-
CCAAGGGAAGGGTCCGTGC, andRI5, 5′-CTACCA-
GCTCCTTGGCCTTGTGG (Paassilta et al., in press).
PCR amplifications were performed in a reaction volume
of 30 ml containing 60 ng genomic DNA, 5 pmol each
primer, 200 mM dNTP, 1.5 mM MgCl, and 1 U Taq
polymerase (AmpliTaq Gold, Perkin-Elmer). The DNA
samples were amplified for 35 cycles at 94.5C for 40
s, 60C for 50 s, and 72C for 1 min, followed by one
extension cycle at 72C for 10 min. Allelic inheritance
of the intragenic markers was analyzed by conforma-
tion-sensitive gel electrophoresis (CSGE). Microsatellite
markers were used to analyze linkage to chromosome
19 (D19S212, D19S215, and D19S222) and to chro-
mosome 1 (D1S211 and L-MYC). The sequences of the
primers and the conditions for PCR amplification have
been described elsewhere (Ma¨kela¨ et al. 1992; Weissen-
bach et al. 1992).
PCR Amplification of COL9A3
The PCR primers were designed to amplify all 32 ex-
ons and exon boundaries of COL9A3 (Paassilta et al.,
in press). The lengths of the PCR products varied from
209 to 411 bp, and each contained 70 bp of the exon-
flanking sequences. Genomic DNA was amplified in a
volume of 40 ml with thermal cycling of 45 s at 94C,
45 s at 60–63C, and 1 min at 72C, for 30 cycles, and
10 min at 72C for 1 cycle, followed by denaturation at
95C for 5 min and incubation at 68C for 30 min, to
generate heteroduplexes. The PCR products were ana-
lyzed on 1.5% agarose gels.
Heteroduplex Analysis
The CSGE method was used to analyze the PCR prod-
ucts for the presence of heteroduplexes. A CSGE gel was
prepared with 10% polyacrylamide, 99:1 ratio of ac-
rylamide (Intermountain Scientific) to 1,4-bis(acryloyl)
piperazine (Fluka), 10% (vol/vol) ethylene glycol
(Sigma), 15% (vol/vol) formamide (Gibco), 0.1% am-
monium persulphate (U.S. Biochemicals), and 0.07%
N,N,N′,N′-tetramethylethylenediamine (Sigma) in 0.5#
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Table 1
Clinical and Radiological Findings
Subject Sex
Year of
Birth
Height
(cm) Area of Clinical Complaint Results of Clinical Examination
Affected Joints
(radiographs)
II-2 M 1932 168 Knees, hips Limited extension of knees and elbows,
replaced left hip, valgus knees Knees, hips
II-4 M 1942 171 Minor knee pain No abnormalities Not done
II-5 F 1945 160 Knees, hips Limited extension of knees Knees
III-2 M 1957 169 Severe knee pain Limited extension of knees and hips,
mild valgus knees Knees, hips, ankles, wrists
III-3 M 1967 180 Knees Knee crepitation Knees
III-5 M 1979 187 Knees Knee crepitation Knees, hips
III-6 M 1968 Not known Knees Not done Not done
IV-1 M 1986 148 Severe knee pain Limited extension of elbows, hips and
knees, valgus knees Knees, hips, ankles, hands
TTE (44 mMTris/14.5 mMTaurine/0.1mMEDTA, [pH
9.0]) buffer. A standard DNA-sequencing apparatus was
used for gel electrophoresis with 0.5# TTE as the elec-
trode buffer. The gel was preelectrophoresed at 45 W
for 15 min. A total of 50–75 ng PCR products were
mixed with loading buffer (10# stock solution of 30%
glycerol containing 0.25% both xylene cyanol FF and
bromphenol blue), and the mixture was loaded on a
CSGE gel. The samples were electrophoresed for 5 h at
room temperature at 45 W, after which the gel was
stained with ethidium bromide and photographed (Gan-
guly et al. 1993; Ko¨rkko¨ et al. 1998).
Sequencing of PCR Products
The samples that contained heteroduplexes were
treated with exonuclease I and shrimp alkaline phos-
phatase by incubation at 37C for 15 min followed by
inactivation at 80C for 15 min. They were then ana-
lyzed by automated sequencing (ABI PRISM model 377
Sequencer and dRhod Dye Terminator Cycle Sequencing
Ready Reaction Mix, Perkin-Elmer).
RNA Analysis
RNA was extracted from Epstein-Barr virus (EBV)–
transformed lymphoblasts obtained from an individual
in the control group, EBV-transformed lymphoblasts ob-
tained from a proband, and primary cultured chondro-
cytes obtained from one affected family member during
hip surgery, by the acid guanidium thiocyanate/phenol/
chloroform method (Chomczynski and Sacchi 1987).
The Superscript Preamplification System (Gibco BRL)
with random hexamers was used to synthesize the first-
strand cDNA. PCR primers corresponding to exons 1
(E1F, 5′-CGCGCCGCTCCTGCTCCTGCTCCTC) and
9 (E9R, 5′-ACCAGGGAGGCCGGGGAGTCCAGA) of
the a3(IX) cDNA (Brewton et al. 1995) were used for
the first PCR amplification, whereas the second was per-
formed by use of nested PCR primers from exons 1
(E1Fb, 5′-GGCGGCCGCCGGGGCGCAGAGA) and 6
(E6R, 5′-GGGCGGCCCCGGGGGTCCCAGACTTC).
The PCR amplifications took place in a volume of 50
ml with 1 ml of the PCR template, 10 pmol each primer,
and 1 U Taq polymerase. Thermal cycling conditions
included one cycle at 95C for 2 min and 35 cycles at
95C for 40 s, 58C–62C for 50 s, and 72C for 1 min,
followed by one extension cycle at 72C for 10 min. The
products from the second PCR reaction were analyzed
on 4% agarose gels, cloned into the pUC 18 vector
(SURE Clone Ligation Kit, Pharmacia), and sequenced.
Results
Clinical and Radiological Findings
A four-generation family with autosomal dominant
osteochondrodysplasia MED was studied (fig. 1). All the
affected family members experienced knee pain and stiff-
ness during childhood. They all experienced difficulties
in walking as a result of these symptoms, and some
developed hip arthrosis and required surgical hip re-
placement after age 50 years. The affected adults had
normal hands and no spinal symptoms, and their height
was normal (1 SD to  1 SD) and did not differ from
that of the unaffected family members. The phenotype
of the family members varied(table 1).
Radiographs of the male proband II-2 taken at age
59 years showed irregular and slightly narrow epiphyses
of the knees (not shown). Radiographs of his hips
showed narrowing of the joint spaces and osteophyte
formation. The capital femoral epiphyses were smaller
than normal, and the acetabuli were slightly hypoplastic
(not shown). The proband had left hip replacement at
age 63 years. Radiographs of subject III-5 (a nephew of
the proband), taken at age 16 years, indicated small
irregularities of the lateral condyles of the distal femoral
epiphyses and slight narrowing of the internal com-
partment (not shown). Radiographs of his hips showed
mild condensation of the acetabulum (not shown). Ra-
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Figure 2 Roentgenograms of the knees (A), pelvis (B), and hands (C) of subject IV-1
diographs of subject III-2 (the proband’s son), taken at
age 12 years, showed osteochondritis dissecans of the
left femoral condyle and irregularities of the lower epiph-
yses of the knees, the carpal bones, and the epiphyses
of the ankle (not shown). The proband’s grandson, sub-
ject IV-1, showed flattened, irregular, and fragmented
distal femoral epiphyses at age 8 years (fig. 2A). His hip
epiphyses were flat and underdeveloped (fig. 2B), the
carpal bones were irregular and small, and the meta-
carpal bones were shortened (fig. 2C). Radiographs of
the spine showed normal findings (not shown). Although
the radiologic findings of the adult affected family mem-
bers showed mild dysplasia, the diagnosis of MED was
established on the basis of the radiographs of the
younger individuals. Clinical and radiologic findings for
most of the affected family members are shown in table
1. One family member, subject IV-2, showed multiple
exostoses at the knee level, without any signs of MED.
Linkage and Mutation Analysis
Linkage with four candidate genes,COMP, COL9A1,
COL9A2, and COL9A3, was tested. Recombination
was observed between COMP, COL9A1, or COL9A2
and the MED phenotype in this family, but an inheri-
tance pattern consistent with linkage was found between
the phenotype and an intragenic polymorphism in the
COL9A3 gene (fig. 1). Two affected family members
(subjects II-2 and III-2) and two unaffected ones (sub-
jects III-1 and IV-2) were analyzed for mutations in
COL9A3. The PCR products of all the exons and exon
boundaries were analyzed with CSGE, and those that
contained heteroduplexes in CSGE were sequenced.
CSGE analysis of exon 3 showed a unique heteroduplex
in both affected family members but not in the unaf-
fected members. Six additional family members were an-
alyzed for the presence of the heteroduplex, which was
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Figure 3 CSGE analysis of exon 3. Heteroduplexes were de-
tected in all the affected family members (seefig. 1).
Figure 4 Sequencing of the PCR products from exon 3. A, Se-
quence of the mutated allele. Transversion of ArT (A2IVS2rT) is
indicated by an arrow. B, Sequence of the wild-type allele.
coinherited by all the affected members (figs.1and 3).
Sequencing of exon 3 showed an ArT mutation at the
acceptor site (A2IVS2rT) of intron 2 (fig. 4A). The
mutation was not present in DNAs from unaffected fam-
ily members (fig. 4B). In addition, the mutation was not
found in 130 control alleles. The presence of the mu-
tation in all the affected family members was confirmed
by sequencing and by digestion with TspRI restriction
endonuclease (data not shown).
RNA Analysis
To study the consequences of the mutation for mRNA
splicing, total RNA was prepared from EBV-immortal-
ized lymphoblasts from the proband (subject II-2) and
from an individual in the control group. In addition,
RNA was extracted from cultured chondrocytes from
the proband’s affected sister, subject II-5. RNA samples
were reverse transcribed (RT) and PCR products from
exons 1–9 were generated. Nested primers were used for
the second PCR, to amplify the PCR products from ex-
ons 1–6. Two major products of ∼280 bp and ∼240 bp
were obtained from lymphoblast RNA (fig. 5A) and
chondrocyte RNA (not shown). Control RNA gave one
product of ∼280 bp (fig. 5B). The sequence of the ∼280-
bp PCR product corresponded to that of the wild-type
allele (data not shown). Sequencing of the ∼240-bp PCR
product indicated a skipping of exon 3 and thus deletion
of 36 nucleotides (fig. 6).
Discussion
Linkage studies have suggested at least three loci for
MED, namely EDM1, EDM2, and a third unidentified
locus (Briggs et al. 1994; Oehlmann et al. 1994; Deere
et al. 1995). Here we excluded linkage to the EDM1
and EDM2 loci in a family with MED, but no recom-
bination was observed between the disease and a third
locus, COL9A3 (EDM3), on chromosome 20 (Brewton
et al. 1995). SeveralMEDmutations have been described
in COMP, corresponding to the EDM1 locus (Briggs et
al. 1995; Cohn et al. 1996; Ballo et al. 1997; Susic et
al. 1997; Briggs et al. 1998; Loughlin et al. 1998), and
one in COL9A2, corresponding to the EDM2 locus
(Muragaki et al. 1996). We now describe a splice-site
mutation in COL9A3, leading to skipping of exon 3 and
an in-frame loss of 12 amino acid residues in the COL3
domain of the a3(IX) chain. The consequence of this
mutation for the a3(IX) chain is identical to that re-
ported for the a2(IX) chain (Muragaki et al. 1996).
The sizes of the domains and the amino acid sequences
of the a1(IX), a2(IX), and a3(IX) chains are highly con-
served (Pihlajamaa et al. 1998), and they form hetero-
trimeric molecules that consist of three a chains in a 1:
1:1 ratio. Because COL9A2 and COL9A3 mutations
can cause MED, one could expect COL9A1 to be an-
other locus for MED. The phenotype caused by the
COL9A3 mutation is similar to that caused by the mu-
tation in the COL9A2 gene, thus emphasizing the po-
1042 Am. J. Hum. Genet. 64:1036–1044, 1999
Figure 6 Sequence of the 240-bp RT-PCR product (fig. 5A),
which was cloned to the pUC 18 vector. Sequencing with reverse prim-
ers showed deletion of the sequences for exon 3. The vertical line (top)
indicates the boundary between exons 2 and 4. The boxes (bottom)
indicate the cloned cDNA region (drawn to scale). The PCR primers
used for the second PCR are indicated with arrows (bottom).
Figure 5 Agarose gel electrophoresis of a3(IX) RT-PCR products. RNA was isolated from the EBV-transformed lymphoblasts of the
proband (A) and a control individual (B) and used for cDNA synthesis. The second PCR was performed with exon 1 and six specific nested
primers. Two PCR products were obtained, a 280-bp product corresponding to the wild-type allele (Wt) and a 240-bp product corresponding
to the allele with a deletion (Del). “RT” denotes RT-PCR products of the proband; “M” denotes molecular weight marker; and “C” denotes
RT-PCR product of the control sample.
tential role of the COL3 domain in the pathogenesis of
MED. Initial association of collagen a chains occurs
through the C-terminal ends of the molecules (Engel and
Prockop 1991; Mechling et al. 1996) and is followed by
triple helix formation that progresses from the C ter-
minus toward the N terminus. Hence, the effect of the
deletion in the COL3 domain is likely to propagate to-
ward the N terminus and may thus alter the structure
and function of the most N-terminal portion of the
molecule.
The Ribbing type of MED includes flat epiphyses,
leading to early-onset osteoarthritis in the hips and short
stature. The more severe Fairbank type is characterized
by dwarfism, stubby fingers, and small epiphyses of sev-
eral joints, including the hips (Ribbing 1937; Fairbank
1947; Barrie et al. 1958; Silverman 1996). The wide
variability in MED phenotypes nevertheless makes clas-
sification difficult, and many families with MED remain
unclassified because of the absence of typical Ribbing
or Fairbank features. So far, mutations in COMP and
COL9A2 have been shown to cause MED phenotype.
The phenotype caused by a mutation in COL9A2 does
not exhibit significant involvement of the hip joints and
seems to be milder than the phenotypes caused by mu-
tations inCOMP. (Weaver et al. 1993; Briggs et al. 1994;
van Mourik et al. 1998). The MED phenotype described
here is also relatively mild and closely related to the
phenotype caused by a mutation in COL9A2, because
the affected individuals were of normal or slightly short
stature and showed involvement of the knee joints.How-
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ever, some individuals with the COL9A3 mutation
showed significant hip involvement. The COL9A3 mu-
tation thus results in a phenotype that overlaps with the
phenotype caused by the COL9A2 mutation but differs
from it in the presence of hip involvement. Because the
COL9A2 and COL9A3 mutations affect the respective
collagen chains in identical ways, differences in the phe-
notypes could be a result of additional factors (genetic
or environmental) that modulate the phenotypic severity
and account for the intrafamilial variability seen inMED
(van Mourik et al. 1998). The results suggest that phe-
notypes caused by collagen IXmutations could bemilder
than ones caused by COMP mutations. Identification of
additional mutations, however, is needed to define the
full clinical spectrum of MED caused by collagen IX
mutations.
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